Induction of nitric oxide synthase in Fas-mediated apoptosis in hematopoietic cells
1996 Selleri, Carmine; Sato, T; Raiola, A; Rotoli, B; Young, Ns; Maciejewski, Jp
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia
1996 Selleri, Carmine; Sato, T; Delvecchio, L; Luciano, L; Barrett, Aj; Rotoli, B.
Interferon-gamma, constitutively expressed in the stromal microenviroment of human bone marrow cultures, mediates potent hematopoietic inhibition
1995 Selleri, Carmine; Maciejewski, Jp; Young, Ns
IFN-gamma's negative and positive effects on human hematopoietic cells role of STAT1/STAT3 phosphorylation AND IRF-1 induction
1996 Sato, T; Selleri, Carmine; Maciejewski, Jp; Young, Ns
Marrow and circulating LTC-ICs are decreased after allogeneic bone marrow transplant
1997 Selleri, Carmine; Maciejewski, Jp; Raiola, A; Risitano, Am; Delvecchio, L; Luciano, L; De Rosa, G; Rotoli, B.
Fas mediated modulation of BCR/ABL in chronic myelogenous leukemia results in differential effects on apoptosis and correlates with clinical response to IFN-alpha
1997 Selleri, Carmine; Maciejewski, Jp; Pane, F; Luciano, L; Raiola, A; Risitano, Am
Expression of cellular receptors for interferon-gamma, tumor necrosis factor-alpha and Fas on BM CD34(+) cells
1995 Sato, T; Selleri, Carmine; Anderson, S; Young, Ns; Maciejewski, Jp
Determination of LTC-IC numbers in patients with myelodysplastic syndromes
1996 Sato, T; Kim, S; Selleri, Carmine; Young, Ns; Maciejewski, Jp
Peripheral blood mononuclear cells from paroxysmal nocturnal hemoglobinuria (PNH) patients inhibit the growth of native but not of PIPL-C treated normal hematopoietic progenitors
1995 Rotoli, B; Notaro, R; Selleri, Carmine; de Grazia, C; Luzzatto, L.
Immunosuppression by alemtuzumab for the treatment of bone marrow failure of bone marrow failure syndromes
2008 Risitano, Am; Seneca, E; Marando, L; Serio, B; Iori, Ap; Del Vecchio, L; Selleri, Carmine; Rotoli, B.
Clonal T-cell populations attacking the haematopoietic tissue are responsible for immune-mediated aplastic anemia and pathogenically related marrow failure syndromes
2005 Risitano, A; Young, N; Maciejewski, J; Wlodarski, M; Pane, F; Selleri, Carmine; Rotoli, B.
Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA)
2008 Risitano, A; Marando, L; Selleri, Carmine; Serio, B; Seneca, E; Camera, A; L., Catalano; G., Scalia; L., Del Vecchio; A., Iori; S., Maury; A., Bacigalupo; G., Sociè; A., Tichelli; J., Marsh
Management of paroxysmal nocturnal haemoglobinuria in the eculizumab era: the bedside and beyond
2008 Risitano, Am; Marando, L; Hill, A; Ranaldi, D; Seneca, E; Serio, B; Ricci, P; Selleri, Carmine; Gianfaldoni, G; Mannelli, F; Milano, F; Amendola, A; Boschetti, C; Di Bona, E; Bonfigli, S; Barbano, F; Rodeghiero, F; Zanella, A; Iori, Ap; Notaro, R; Rother, Rp; Kroon, Ha; Hillmen, P; Luzzatto, L; Rotoli, B.
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes
2010 Pascariello, C; Selleri, Carmine; Del Vecchio, L; Sica, M; Horvath, C; Holers, M.
LTC-IC in aplastic anemia
1996 Maciejewski, Jp; Kim, S; Sato, T; Selleri, Carmine; Young, Ns
Imatinib in 34 patients with steroid-refractory chronic graft-versus-host-disease: final evaluation of the second prospective trial, according to the NIH Consensus criteria for cGvHD
2012 Messina, Giuseppe; Giaccone, Luisa; Festuccia, Moreno; Irrera, Giuseppe; Scortechini, Ilaria; Sorasio, Roberto; Gigli, Federica; Passera, Roberto; Cavattoni, Irene; Filippi, Andrea Riccardo; Carnevale Schianca, Fabrizio; Pini, Massimo; Risitano, Antonio M; Selleri, Carmine; Levis, Alessandro; Mordini, Nicola; Gallamini, Andrea; Pastano, Rocco; Casini, Marco; Aglietta, Massimo; Montanari, Mauro; Console, Giuseppe; Boccadoro, Mario; Ricardi, Umberto; Bruno, Benedetto
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients
1995 Luciano, L; Giordano, R; Raso, Am; Fontana, R; Attingenti, E; Rocco, S; Parasole, R; Raiola, Am; Selleri, Carmine; Rotoli, B.
Nitric-oxide suppression of human hematopoiesis in vitro. Nitric oxide synthase is present in CD34+ cells and induced by interferon-gamma and tumor necrosis factor-alfa
1995 Maciejewski, J; Selleri, Carmine; Sato, T; Cho, H; Keefer, Lk; Nathan, Cf
Stem cell transplantation (SCT) complicated by hepatitis B (HBV) and hepatitis C (HCV) virus infection: A multicenter study from gitmo (SCT Italian group).
1999 Locasciulli, A; Nava, S; Meloni, G; Alessandrino, P; Cesana, C; De Rosa, G; Selleri, Carmine; Bergonzi, C; Irrera, G; Raimondi, R; Cesaro, S; Arcese, Wg; Bacigalupo, A; Biondi, A.
Immunologic reconstitution after autologous transplant with bone marrow or peripheral blood stem cells
1999 De Rosa, G; Pezzullo, L; Risitano, A; Severino, A; Cavalcanti, R; Cosentini, E; Cacciapuoti, C; Selleri, Carmine; Picardi, M; Rocco, S; Rotoli, B.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Induction of nitric oxide synthase in Fas-mediated apoptosis in hematopoietic cells | 1-gen-1996 | Selleri, Carmine; Sato, T; Raiola, A; Rotoli, B; Young, Ns; Maciejewski, Jp | |
| Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia | 1-gen-1996 | Selleri, Carmine; Sato, T; Delvecchio, L; Luciano, L; Barrett, Aj; Rotoli, B. | |
| Interferon-gamma, constitutively expressed in the stromal microenviroment of human bone marrow cultures, mediates potent hematopoietic inhibition | 1-gen-1995 | Selleri, Carmine; Maciejewski, Jp; Young, Ns | |
| IFN-gamma's negative and positive effects on human hematopoietic cells role of STAT1/STAT3 phosphorylation AND IRF-1 induction | 1-gen-1996 | Sato, T; Selleri, Carmine; Maciejewski, Jp; Young, Ns | |
| Marrow and circulating LTC-ICs are decreased after allogeneic bone marrow transplant | 1-gen-1997 | Selleri, Carmine; Maciejewski, Jp; Raiola, A; Risitano, Am; Delvecchio, L; Luciano, L; De Rosa, G; Rotoli, B. | |
| Fas mediated modulation of BCR/ABL in chronic myelogenous leukemia results in differential effects on apoptosis and correlates with clinical response to IFN-alpha | 1-gen-1997 | Selleri, Carmine; Maciejewski, Jp; Pane, F; Luciano, L; Raiola, A; Risitano, Am | |
| Expression of cellular receptors for interferon-gamma, tumor necrosis factor-alpha and Fas on BM CD34(+) cells | 1-gen-1995 | Sato, T; Selleri, Carmine; Anderson, S; Young, Ns; Maciejewski, Jp | |
| Determination of LTC-IC numbers in patients with myelodysplastic syndromes | 1-gen-1996 | Sato, T; Kim, S; Selleri, Carmine; Young, Ns; Maciejewski, Jp | |
| Peripheral blood mononuclear cells from paroxysmal nocturnal hemoglobinuria (PNH) patients inhibit the growth of native but not of PIPL-C treated normal hematopoietic progenitors | 1-gen-1995 | Rotoli, B; Notaro, R; Selleri, Carmine; de Grazia, C; Luzzatto, L. | |
| Immunosuppression by alemtuzumab for the treatment of bone marrow failure of bone marrow failure syndromes | 1-gen-2008 | Risitano, Am; Seneca, E; Marando, L; Serio, B; Iori, Ap; Del Vecchio, L; Selleri, Carmine; Rotoli, B. | |
| Clonal T-cell populations attacking the haematopoietic tissue are responsible for immune-mediated aplastic anemia and pathogenically related marrow failure syndromes | 1-gen-2005 | Risitano, A; Young, N; Maciejewski, J; Wlodarski, M; Pane, F; Selleri, Carmine; Rotoli, B. | |
| Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA) | 1-gen-2008 | Risitano, A; Marando, L; Selleri, Carmine; Serio, B; Seneca, E; Camera, A; L., Catalano; G., Scalia; L., Del Vecchio; A., Iori; S., Maury; A., Bacigalupo; G., Sociè; A., Tichelli; J., Marsh | |
| Management of paroxysmal nocturnal haemoglobinuria in the eculizumab era: the bedside and beyond | 1-gen-2008 | Risitano, Am; Marando, L; Hill, A; Ranaldi, D; Seneca, E; Serio, B; Ricci, P; Selleri, Carmine; Gianfaldoni, G; Mannelli, F; Milano, F; Amendola, A; Boschetti, C; Di Bona, E; Bonfigli, S; Barbano, F; Rodeghiero, F; Zanella, A; Iori, Ap; Notaro, R; Rother, Rp; Kroon, Ha; Hillmen, P; Luzzatto, L; Rotoli, B. | |
| A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes | 1-gen-2010 | Pascariello, C; Selleri, Carmine; Del Vecchio, L; Sica, M; Horvath, C; Holers, M. | |
| LTC-IC in aplastic anemia | 1-gen-1996 | Maciejewski, Jp; Kim, S; Sato, T; Selleri, Carmine; Young, Ns | |
| Imatinib in 34 patients with steroid-refractory chronic graft-versus-host-disease: final evaluation of the second prospective trial, according to the NIH Consensus criteria for cGvHD | 1-gen-2012 | Messina, Giuseppe; Giaccone, Luisa; Festuccia, Moreno; Irrera, Giuseppe; Scortechini, Ilaria; Sorasio, Roberto; Gigli, Federica; Passera, Roberto; Cavattoni, Irene; Filippi, Andrea Riccardo; Carnevale Schianca, Fabrizio; Pini, Massimo; Risitano, Antonio M; Selleri, Carmine; Levis, Alessandro; Mordini, Nicola; Gallamini, Andrea; Pastano, Rocco; Casini, Marco; Aglietta, Massimo; Montanari, Mauro; Console, Giuseppe; Boccadoro, Mario; Ricardi, Umberto; Bruno, Benedetto | |
| Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients | 1-gen-1995 | Luciano, L; Giordano, R; Raso, Am; Fontana, R; Attingenti, E; Rocco, S; Parasole, R; Raiola, Am; Selleri, Carmine; Rotoli, B. | |
| Nitric-oxide suppression of human hematopoiesis in vitro. Nitric oxide synthase is present in CD34+ cells and induced by interferon-gamma and tumor necrosis factor-alfa | 1-gen-1995 | Maciejewski, J; Selleri, Carmine; Sato, T; Cho, H; Keefer, Lk; Nathan, Cf | |
| Stem cell transplantation (SCT) complicated by hepatitis B (HBV) and hepatitis C (HCV) virus infection: A multicenter study from gitmo (SCT Italian group). | 1-gen-1999 | Locasciulli, A; Nava, S; Meloni, G; Alessandrino, P; Cesana, C; De Rosa, G; Selleri, Carmine; Bergonzi, C; Irrera, G; Raimondi, R; Cesaro, S; Arcese, Wg; Bacigalupo, A; Biondi, A. | |
| Immunologic reconstitution after autologous transplant with bone marrow or peripheral blood stem cells | 1-gen-1999 | De Rosa, G; Pezzullo, L; Risitano, A; Severino, A; Cavalcanti, R; Cosentini, E; Cacciapuoti, C; Selleri, Carmine; Picardi, M; Rocco, S; Rotoli, B. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1217
Data di pubblicazione
- 2020 - 2026128
- 2010 - 2019457
- 2000 - 2009357
- 1990 - 1999217
- 1980 - 198957
- 1978 - 19791
Editore
- wiley blackwell1
Rivista
- DIGESTIVE AND LIVER DISEASE53
- HAEMATOLOGICA53
- JOURNAL OF ALLERGY AND CLINICAL I...45
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...44
- BLOOD42
- JOURNAL OF PEDIATRIC GASTROENTERO...37
- RIVISTA DI STUDI POLITICI INTERNA...28
- ANNALS OF ONCOLOGY27
- BONE MARROW TRANSPLANTATION25
- CIRCULATION23
Keyword
- pediatrics109
- Novità12
- Humans3
- Ring closure reactions3
- rinvenimenti monetali3
- Animals2
- autologous bone graft2
- Cardiovascular Diseases2
- Covid-192
- Green extraction technologies2
Lingua
- eng899
- ita99
- fre2
- cze1
Accesso al fulltext
- no fulltext1216
- open1